Thapsigargin
- Molecular formula
- C34H54N4O10
- CAS Number
- 67526-95-8
- IUPAC Name
- N-[4-(2-amino-1H-imidazol-5-yl)cyclohexyl]-2-(2,2-diphenylethyl)-6-methyl-1,3-dioxo-5,8-dihydro-[1,2,4]triazolo[1,2-a]pyridazine-8-carboxamide
- Molecular Weight
- 650.76g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3000g/cm3
Identification
Interesting Facts about N-[4-(2-amino-1H-imidazol-5-yl)cyclohexyl]-2-(2,2-diphenylethyl)-6-methyl-1,3-dioxo-5,8-dihydro-[1,2,4]triazolo[1,2-a]pyridazine-8-carboxamide
This compound represents a fascinating intersection of pharmacology and synthetic organic chemistry. It belongs to a class of compounds known for their diverse biological activities and potential therapeutic applications.
Key Features
- Complex Structure: The compound has a complex molecular architecture that combines multiple ring systems, which can contribute to its unique reactivity and properties.
- Potential Biological Activity: The presence of the imidazole and triazole rings suggests that this compound may exhibit interesting pharmacological properties, potentially interacting with various biological targets, such as enzymes or receptors.
- Pharmaceutical Relevance: Compounds like this are often investigated in drug discovery, as modifications to their structure may lead to enhanced efficacy and reduced toxicity.
Research Insights
Scientists are increasingly exploring compounds with such intricate structures for their potential to address unmet medical needs. According to various studies, modifications in these chemical systems can lead to:
- Improved drug action through alterations in binding affinity.
- Stability enhancements that may influence therapeutic administration.
- Reduced side effects, leading to better patient compliance.
In conclusion, the molecular intricacies of this compound open up a world of possibilities for scientific inquiry and medicinal chemistry. As research evolves, such compounds will continue to be essential in the quest for innovative treatments.